Results
1 -
10 of
84Impact of Genetic Targets on Cancer Therapy in Acute Myelogenous Leukemia, Impact of Genetic Targets on Cancer Therapy Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML, International Journal of Hematology New Indole-Containing Medicinal Compounds, Heterocyclic Scaffolds II: Inhibition der Signaltransduktionnals therapeutisches Prinzip, Der Onkologe Activation of HIV-1 expression in latently infected CD4+ T cells by the small molecule PKC412, Virology Journal Chemotherapy Options for Poor Responders to Neoadjuvant Chemotherapy for Orbital Granulocytic Sarcoma, Current Treatment Options in Oncology FLT3 Inhibitors as Therapeutic Agents in MLL Rearranged Acute Lymphoblastic Leukemia, New Agents for the Treatment of Acute Lymphoblastic Leukemia Cytogenetic and Molecular Aberrations as Predictive Biomarkers in Acute Myeloid Leukemia, Biomarkers in Oncology